Multiple lawsuits have been filed all over the United States against Bayer, and Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals for blood thinning drug, Xarelto, which has caused hundreds of deaths and thousands of serious bleeding cases. Victims are claiming that Bayer used misleading marketing tactics by advertising that Xarelto was safer to use than another common blood thinner, Warfarin, and that the company did not adequately warn users of the risks. Xarelto (rivaroxaban) is an oral medication that is supposed to prevent blood clots, which can prevent blood from reaching vital organs. It is different from other anticoagulants in that it can be taken in one universal dose, rather than be prescribed in different doses per individual. It was approved by the Food and Drug Administration in 2011 to reduce the risk of blood clots for patients who had gone through knee and hip replacement surgery, and to prevent strokes in patients with heart disease. In 2012 reports of wrongful death and serious uncontrollable bleeding began flooding in, as well as reports of dangerous blood clots, the kind the drug was supposed to prevent. The most dangerous side effect, uncontrollable bleeding, is almost impossible to stop, because unlike other blood thinners, it has no antidote. Patients who experience internal bleeding from Xarelto have to wait until it is flushed out of the system. Affected patients have reported bleeding from the rectum, intestinal or abdominal bleeds, hemorrhaging, and bleeding in the brain. It can even cause spinal bleeding (epidural or spinal hematomas), which can cause permanent paralysis.
Pradaxa, a similar drug, marketed by Bayer’s competitor, Boehringer-Ingelheim, has been the subject of numerous lawsuits as well for the same reasons, forcing its maker to pay $650 million in severe injury and wrongful death claims. Victims of dangerous side effects caused by Xarelto and Pradaxa have filed for compensation for medical bills, injuries, and emotional trauma, and allege that the companies continue to keep the drugs on the market despite obvious dangers. In a recent study to determine Xarelto’s safety, 73% of participants experienced side effects, with anemia and abnormal bleeding among the most common.
If you or a loved one have experienced traumatic side effects from blood thinning drugs such as Xarelto, and require monetary compensation for your losses, the lawyers at Hodes Milman Liebeck are there for you in your time of need. Contact us today online at hmlm.com or call 866-730-1976 for a complimentary case evaluation.